Chiesi Group has appointed David Khougazian as Group Chief Executive Officer (CEO). Khougazian joins Chiesi following an international career spanning more than 25 years across the global healthcare and life sciences sectors.
Most recently, he served as Executive Partner, Growth, and Head of Global Engagement at Flagship Pioneering, where he supported the growth and development of science-driven healthcare companies and worked closely with leadership teams on long-term value creation, partnerships, financing and organisational development.
Following a thorough selection process led by the Board of Directors, Khougazian will succeed Interim Group CEO Jean-Marc Bellemin, who has successfully led the Group since 15 May 2026, while also continuing in his permanent role as Group CFO.
Maria Paola Chiesi, Chiesi Group Chair, commented: “Innovation has always been at the heart of Chiesi’s mission and long-term vision. David’s appointment reflects our ambition to accelerate this journey and strengthen Chiesi’s ability to innovate in a healthcare environment that is changing faster than ever.
“David brings a unique combination of global healthcare leadership, operational experience and exposure to some of the most dynamic areas of biotech innovation, which makes him exceptionally well positioned to guide Chiesi through this next chapter.
Khougazian commented: “The healthcare landscape is evolving rapidly, creating extraordinary opportunities to advance innovation and transform patient outcomes. I look forward to working alongside Chiesi colleagues around the world to further strengthen the Group’s innovation capabilities, advance its pipeline and partnerships, and create lasting value for patients, healthcare systems and society.”